Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096004953> ?p ?o ?g. }
- W3096004953 endingPage "174" @default.
- W3096004953 startingPage "165" @default.
- W3096004953 abstract "Background Neuroleptics are commonly prescribed drugs to treat acute conditions (e.g., migraines) in the emergency department, but can cause serious adverse effects. Using diphenhydramine to prevent these adverse effects is very common but remains controversial. Objective We performed a systematic review to determine whether prophylactic administration of diphenhydramine reduces the incidence of neuroleptic adverse effects in patients with acute conditions. Methods Medline, Embase, Cochrane, PsycInfo, and Web of Science were searched for randomized controlled trials evaluating any neuroleptic with diphenhydramine vs. the same neuroleptic with any inactive agent. Primary outcome was incidence of any extrapyramidal adverse effect. Secondary outcomes were akathisia, rescue medication, subjective restlessness, neuroleptic malignant syndrome, and sedation. Independent reviewers scanned identified citations, extracted data, and assessed risk of bias. Meta-analysis was performed using random effect models. Results Of 1566 identified citations, nine studies (n = 1648 patients) met eligibility criteria. Four studies were specifically designed to compare the incidence of neuroleptic adverse effects with and without co-administration of diphenhydramine. Four studies were at high risk of bias. In primary analysis, diphenhydramine had no effect on the incidence of extrapyramidal symptoms (7 studies, n = 1393, risk ratio [RR] 0.75; 95% confidence interval [CI] 0.44–1.31) or akathisia (5 studies, n = 1094; RR 0.78; 95% CI 0.33–1.82) or any of the secondary outcomes. In subgroup analysis, diphenhydramine was associated with a significant decrease in extrapyramidal adverse effects compared with placebo (4 studies, n = 705; RR 0.61; 95% CI 0.41–0.90). Dosage analysis yielded no further information. Conclusions When compared with placebo, diphenhydramine was associated with a significant reduction of extrapyramidal adverse effects. Overall quality of evidence is low. Further studies are warranted." @default.
- W3096004953 created "2020-11-09" @default.
- W3096004953 creator A5003167686 @default.
- W3096004953 creator A5017146595 @default.
- W3096004953 creator A5017528505 @default.
- W3096004953 creator A5056397261 @default.
- W3096004953 date "2021-02-01" @default.
- W3096004953 modified "2023-10-12" @default.
- W3096004953 title "Prophylactic Administration of Diphenhydramine to Reduce Neuroleptic Side Effects in the Acute Care Setting: A Systematic Review and Meta-Analysis" @default.
- W3096004953 cites W1247968195 @default.
- W3096004953 cites W1266320775 @default.
- W3096004953 cites W1928159894 @default.
- W3096004953 cites W1977926796 @default.
- W3096004953 cites W1979982635 @default.
- W3096004953 cites W1983676402 @default.
- W3096004953 cites W2005065187 @default.
- W3096004953 cites W2018316291 @default.
- W3096004953 cites W2022236220 @default.
- W3096004953 cites W2040080216 @default.
- W3096004953 cites W2043350445 @default.
- W3096004953 cites W2048837484 @default.
- W3096004953 cites W2052294852 @default.
- W3096004953 cites W2057135533 @default.
- W3096004953 cites W2057802898 @default.
- W3096004953 cites W2061243723 @default.
- W3096004953 cites W2080222753 @default.
- W3096004953 cites W2096912480 @default.
- W3096004953 cites W2098311556 @default.
- W3096004953 cites W2101184898 @default.
- W3096004953 cites W2112190201 @default.
- W3096004953 cites W2119971225 @default.
- W3096004953 cites W2125435699 @default.
- W3096004953 cites W2141821729 @default.
- W3096004953 cites W2149950019 @default.
- W3096004953 cites W2157823046 @default.
- W3096004953 cites W2160309422 @default.
- W3096004953 cites W2170146596 @default.
- W3096004953 cites W2310905616 @default.
- W3096004953 cites W2767763205 @default.
- W3096004953 cites W2892142575 @default.
- W3096004953 cites W3022903699 @default.
- W3096004953 cites W4295974821 @default.
- W3096004953 doi "https://doi.org/10.1016/j.jemermed.2020.09.031" @default.
- W3096004953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33131965" @default.
- W3096004953 hasPublicationYear "2021" @default.
- W3096004953 type Work @default.
- W3096004953 sameAs 3096004953 @default.
- W3096004953 citedByCount "4" @default.
- W3096004953 countsByYear W30960049532022 @default.
- W3096004953 countsByYear W30960049532023 @default.
- W3096004953 crossrefType "journal-article" @default.
- W3096004953 hasAuthorship W3096004953A5003167686 @default.
- W3096004953 hasAuthorship W3096004953A5017146595 @default.
- W3096004953 hasAuthorship W3096004953A5017528505 @default.
- W3096004953 hasAuthorship W3096004953A5056397261 @default.
- W3096004953 hasConcept C1122143 @default.
- W3096004953 hasConcept C118552586 @default.
- W3096004953 hasConcept C120665830 @default.
- W3096004953 hasConcept C121332964 @default.
- W3096004953 hasConcept C126322002 @default.
- W3096004953 hasConcept C142724271 @default.
- W3096004953 hasConcept C197934379 @default.
- W3096004953 hasConcept C204787440 @default.
- W3096004953 hasConcept C27081682 @default.
- W3096004953 hasConcept C2776412080 @default.
- W3096004953 hasConcept C2776814716 @default.
- W3096004953 hasConcept C2777393122 @default.
- W3096004953 hasConcept C2780494398 @default.
- W3096004953 hasConcept C2780616385 @default.
- W3096004953 hasConcept C2781292560 @default.
- W3096004953 hasConcept C42219234 @default.
- W3096004953 hasConcept C44249647 @default.
- W3096004953 hasConcept C61511704 @default.
- W3096004953 hasConcept C71924100 @default.
- W3096004953 hasConcept C82789193 @default.
- W3096004953 hasConcept C95190672 @default.
- W3096004953 hasConceptScore W3096004953C1122143 @default.
- W3096004953 hasConceptScore W3096004953C118552586 @default.
- W3096004953 hasConceptScore W3096004953C120665830 @default.
- W3096004953 hasConceptScore W3096004953C121332964 @default.
- W3096004953 hasConceptScore W3096004953C126322002 @default.
- W3096004953 hasConceptScore W3096004953C142724271 @default.
- W3096004953 hasConceptScore W3096004953C197934379 @default.
- W3096004953 hasConceptScore W3096004953C204787440 @default.
- W3096004953 hasConceptScore W3096004953C27081682 @default.
- W3096004953 hasConceptScore W3096004953C2776412080 @default.
- W3096004953 hasConceptScore W3096004953C2776814716 @default.
- W3096004953 hasConceptScore W3096004953C2777393122 @default.
- W3096004953 hasConceptScore W3096004953C2780494398 @default.
- W3096004953 hasConceptScore W3096004953C2780616385 @default.
- W3096004953 hasConceptScore W3096004953C2781292560 @default.
- W3096004953 hasConceptScore W3096004953C42219234 @default.
- W3096004953 hasConceptScore W3096004953C44249647 @default.
- W3096004953 hasConceptScore W3096004953C61511704 @default.
- W3096004953 hasConceptScore W3096004953C71924100 @default.
- W3096004953 hasConceptScore W3096004953C82789193 @default.
- W3096004953 hasConceptScore W3096004953C95190672 @default.
- W3096004953 hasIssue "2" @default.